Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OGFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100507507 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR637 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STARD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TELO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYTL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INHBB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFT2D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SERTAD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR1H2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBTD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on